BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10360658)

  • 1. Long-term effects on sexual function and fertility after treatment of testicular cancer.
    Hartmann JT; Albrecht C; Schmoll HJ; Kuczyk MA; Kollmannsberger C; Bokemeyer C
    Br J Cancer; 1999 May; 80(5-6):801-7. PubMed ID: 10360658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retroperitoneal lymphadenectomy for testicular cancer and genito-sexual conditions: retrospective study].
    Castelli E; Terrone C; De Luca S; Rossetti SR
    Prog Urol; 2000 Sep; 10(4):578-82. PubMed ID: 11064900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexuality and body image in long-term survivors of testicular cancer.
    Rossen P; Pedersen AF; Zachariae R; von der Maase H
    Eur J Cancer; 2012 Mar; 48(4):571-8. PubMed ID: 22197218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility after testicular cancer treatments: results of a large multicenter study.
    Huyghe E; Matsuda T; Daudin M; Chevreau C; Bachaud JM; Plante P; Bujan L; Thonneau P
    Cancer; 2004 Feb; 100(4):732-7. PubMed ID: 14770428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.
    Jacobsen KD; Ous S; Waehre H; Trasti H; Stenwig AE; Lien HH; Aass N; Fosså SD
    Br J Cancer; 1999 Apr; 80(1-2):249-55. PubMed ID: 10390004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
    Steiner H; Peschel R; Bartsch G
    BJU Int; 2008 Aug; 102(3):310-4. PubMed ID: 18325053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paternity following treatment for testicular cancer.
    Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
    J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sexual dysfunction in men treated for testicular cancer].
    Rosendal S; Kristensen E; Giraldi AG
    Ugeskr Laeger; 2007 Nov; 169(46):3941-6. PubMed ID: 18078644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
    Beck SD; Bey AL; Bihrle R; Foster RS
    J Urol; 2010 Nov; 184(5):2078-80. PubMed ID: 20850817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testicular germ cell tumors: prognosis].
    Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
    Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG; McCaughan BC; Stockle M; Boyer MJ
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
    Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Grosclaude P
    Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
    Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
    BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.